These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6098453)

  • 1. Neutralization of heat-labile toxin of E. coli by antibodies to synthetic peptides derived from the B subunit of cholera toxin.
    Jacob CO; Pines M; Arnon R
    EMBO J; 1984 Dec; 3(12):2889-93. PubMed ID: 6098453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunity to heat-labile enterotoxins of porcine and human Escherichia coli strains achieved with synthetic cholera toxin peptides.
    Jacob CO; Arnon R; Finkelstein RA
    Infect Immun; 1986 May; 52(2):562-7. PubMed ID: 3009330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological relationships between cholera toxin and Escherichia coli heat-labile enterotoxin.
    Gilligan PH; Brown JC; Robertson DC
    Infect Immun; 1983 Nov; 42(2):683-91. PubMed ID: 6196292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological interrelationships between cholera toxin and the heat-labile and heat-stable enterotoxins of coliform bacteria.
    Klipstein FA; Engert RF
    Infect Immun; 1977 Oct; 18(1):110-7. PubMed ID: 332637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both cholera toxin-induced adenylate cyclase activation and cholera toxin biological activity are inhibited by antibodies against related synthetic peptides.
    Jacob CO; Sela M; Pines M; Hurwitz S; Arnon R
    Proc Natl Acad Sci U S A; 1984 Dec; 81(24):7893-6. PubMed ID: 6595665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Priming immunization against cholera toxin and E. coli heat-labile toxin by a cholera toxin short peptide-beta-galactosidase hybrid synthesized in E. coli.
    Jacob CO; Leitner M; Zamir A; Salomon D; Arnon R
    EMBO J; 1985 Dec; 4(12):3339-43. PubMed ID: 3004953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in cross-protection in rats immunized with the B subunits of cholera toxin and Escherichia coli heat-labile toxin.
    Klipstein FA; Engert RF; Clements JD; Houghten RA
    Infect Immun; 1984 Mar; 43(3):811-6. PubMed ID: 6365784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic determinants of the cholera/coli family of enterotoxins.
    Finkelstein RA; Burks MF; Zupan A; Dallas WS; Jacob CO; Ludwig DS
    Rev Infect Dis; 1987; 9 Suppl 5():S490-502. PubMed ID: 2446368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies against synthetic peptides of the B subunit of cholera toxin: crossreaction and neutralization of the toxin.
    Jacob CO; Sela M; Arnon R
    Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7611-5. PubMed ID: 6584874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential biological and adjuvant activities of cholera toxin and Escherichia coli heat-labile enterotoxin hybrids.
    Bowman CC; Clements JD
    Infect Immun; 2001 Mar; 69(3):1528-35. PubMed ID: 11179323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies to Escherichia coli heat-labile enterotoxins: neutralising activity and differentiation of human and porcine LTs and cholera toxin.
    Svennerholm AM; Wikström M; Lindblad M; Holmgren J
    Med Biol; 1986; 64(1):23-30. PubMed ID: 3724258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological relationship of the B subunits of Campylobacter jejuni and Escherichia coli heat-labile enterotoxins.
    Klipstein FA; Engert RF
    Infect Immun; 1985 Jun; 48(3):629-33. PubMed ID: 3922890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of hybrid molecules between heat-labile enterotoxin and cholera toxin B subunits: potential for use in a broad-spectrum vaccine.
    Lebens M; Shahabi V; Bäckström M; Houze T; Lindblad N; Holmgren J
    Infect Immun; 1996 Jun; 64(6):2144-50. PubMed ID: 8675319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies to cholera toxin with special reference to cross-reactions with Escherichia coli heat-labile enterotoxin.
    Lindholm L; Holmgren J; Wikström M; Karlsson U; Andersson K; Lycke N
    Infect Immun; 1983 May; 40(2):570-6. PubMed ID: 6840852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitopes of the cholera family of enterotoxins.
    Finkelstein RA; Burks MF; Zupan A; Dallas WS; Jacob CO; Ludwig DS
    Rev Infect Dis; 1987; 9(3):544-61. PubMed ID: 2440089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escherichia coli K88ac fimbriae expressing heat-labile and heat-stable (STa) toxin epitopes elicit antibodies that neutralize cholera toxin and STa toxin and inhibit adherence of K88ac fimbrial E. coli.
    Zhang C; Zhang W
    Clin Vaccine Immunol; 2010 Dec; 17(12):1859-67. PubMed ID: 20980482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A tripartite fusion, FaeG-FedF-LT(192)A2:B, of enterotoxigenic Escherichia coli (ETEC) elicits antibodies that neutralize cholera toxin, inhibit adherence of K88 (F4) and F18 fimbriae, and protect pigs against K88ac/heat-labile toxin infection.
    Ruan X; Liu M; Casey TA; Zhang W
    Clin Vaccine Immunol; 2011 Oct; 18(10):1593-9. PubMed ID: 21813665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host response to Escherichia coli heat-labile enterotoxin via two microvillus membrane receptors in the rat intestine.
    Zemelman BV; Chu SH; Walker WA
    Infect Immun; 1989 Oct; 57(10):2947-52. PubMed ID: 2674013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological cross-reactivity between a heat-labile enterotoxin(s) of Escherichia coli and subunits of Vibrio cholerae enterotoxin.
    Clements JD; Finkelstein RA
    Infect Immun; 1978 Sep; 21(3):1036-9. PubMed ID: 361573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunit.
    Pizza M; Fontana MR; Giuliani MM; Domenighini M; Magagnoli C; Giannelli V; Nucci D; Hol W; Manetti R; Rappuoli R
    J Exp Med; 1994 Dec; 180(6):2147-53. PubMed ID: 7964489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.